GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,310 | -41.5% | 19,366 | -33.7% | 0.00% | – |
| Q2 2023 | $56,932 | -24.1% | 29,196 | +59.4% | 0.00% | – |
| Q1 2022 | $75,000 | -75.0% | 18,314 | -21.5% | 0.00% | – |
| Q4 2021 | $300,000 | +27.7% | 23,343 | +7.1% | 0.00% | – |
| Q3 2021 | $235,000 | -53.7% | 21,787 | -60.9% | 0.00% | -100.0% |
| Q2 2021 | $508,000 | +18.7% | 55,675 | +22.7% | 0.00% | 0.0% |
| Q1 2021 | $428,000 | +141.8% | 45,392 | +1.3% | 0.00% | – |
| Q4 2020 | $177,000 | +48.7% | 44,805 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | -60.1% | 44,805 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $298,000 | +30.1% | 44,805 | +14.1% | 0.00% | – |
| Q1 2020 | $229,000 | -34.2% | 39,277 | +1.1% | 0.00% | -100.0% |
| Q4 2019 | $348,000 | +3.9% | 38,833 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $335,000 | -21.5% | 38,833 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $427,000 | +196.5% | 38,369 | +254.3% | 0.00% | – |
| Q1 2019 | $144,000 | -25.8% | 10,828 | -13.5% | 0.00% | – |
| Q4 2018 | $194,000 | – | 12,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |